PRX-100
PRX100.FDAII
Phase 2 small_molecule completed
Quick answer
PRX-100 for Presbyopia is a Phase 2 program (small_molecule) at LENZ Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- LENZ Therapeutics
- Indication
- Presbyopia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed